Drugs & Targets FDA approves Darzalex + lenalidomide and dexamethasone in multiple myeloma patients ineligible for transplant June 28, 2019Vol.45 No.26
Drugs & Targets European Commission approves Trecondi for hematopoietic stem cell transplantation June 28, 2019Vol.45 No.26
Drugs & Targets Intensity Therapeutics, Merck partner to evaluate INT230-6 and Keytruda June 28, 2019Vol.45 No.26
Drugs & Targets Development collaboration will focus on CAR-T cell therapy for breast cancer June 28, 2019Vol.45 No.26
Clinical Roundup CheckMate-459 results for Opdivo don’t meet OS endpoint in hepatocellular carcinoma June 28, 2019Vol.45 No.26
Clinical Roundup Prestige BioPharma report positive top-line phase III results for Tuznue June 28, 2019Vol.45 No.26
Clinical Roundup Prolaris predicts risk of metastasis in localized prostate cancer June 28, 2019Vol.45 No.26
Clinical Roundup NCCN releases patient resource for bladder cancer patients June 28, 2019Vol.45 No.26
